We are monitoring the impact of COVID-19 on Europe Colorectal Cancer Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 564
Share on
Share on

Europe Colorectal Cancer Market Research Report – Segmented By Diagnosis, Treatment & Country (UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic and Rest of Europe) - Industry Analysis, Size, Share, Trends & Growth Forecast (2021 to 2026)

Pulished: April, 2021
ID: 564
Pages: 133

Europe Colorectal Cancer Market Size (2021 to 2026)

The size of the European Colorectal Cancer Market was worth USD 3.36 billion in 2021. It is further forecasted to be growing at a CAGR of 2.45% and worth USD 3.79 billion by 2026.

Colorectal cancer is a consequence of unrestrained cell growth in the appendix, colon, and rectum region. Some of the generally seen symptoms of colorectal cancer are blood in the stool, weight loss, fatigue, and irregular bowel movements.

Colorectal cancer is identified with a biopsy, followed by medical imaging, to know its extent. Depending on the stage and how much cancer has expanded, most oncologists recommend a combination of radiation therapy, chemotherapy, and targeted therapy.

The rise in pipeline colorectal cancer screening tests is one of the major drivers for this region's colorectal cancer market. Another aspect is that European countries face comparable economic and demographic burdens and share an interest in scrutinizing their impact on health outcomes nationally and across Europe.

However, the high cost of treatment is one of the main factors hindering this market's growth.

This research report on the European Colorectal Cancer Market has been segmented and sub-segmented into the following categories:

By Diagnosis:

  • Digital Rectal Examination
  • Fecal Occult Blood Test
  • Flexible Sigmoidoscopy
  • Colonoscopy
  • Virtual Colonoscopy

By Treatment:

  • Surgery and Radiation Therapy
  • Chemotherapy
  • Targeted Therapies
  • Resistance to Pharmacological Therapies

By Country: 

  • UK
  • France
  • Spain
  • Germany
  • Italy
  • Russia
  • Sweden
  • Denmark
  • Switzerland
  • Netherlands
  • Turkey
  • Czech Republic
  • Rest of Europe

Regionally, Europe is the third-largest market with a global share of 24%. Germany is the largest market shareholder for the colorectal Cancer market in this region, followed by the UK and France. Other significant markets in the region are Norway, Netherlands, Denmark, and Greece.

Companies playing a dominating role in the European Colorectal Cancer Market profiled in this report are Abbott Diagnostics, Alere, Beckman Coulter, Clinical Genomics, Companion Dx, Hoffmann La Roche, Debiopharm Group, and Vaccinogen BD.

1. Introduction                 

                1.1 Market Definition    

                1.2 Study Deliverables  

                1.3 Base Currency, Base Year and Forecast Periods          

                1.4 General Study Assumptions

2. Research Methodology                           

                2.1 Introduction               

                2.2 Research Phases      

                                2.2.1 Secondary Research

                                2.2.2 Primary Research

                                2.2.3 Econometric Modelling

                                2.2.4 Expert Validation

                2.3 Analysis Design         

                2.4 Study Timeline          

3. Overview                       

                3.1 Executive Summary

                3.2 Key Inferences         

                3.3 New Developments               

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                    

                4.1 Market Drivers          

                4.2 Market Restraints    

                4.3 Key Challenges         

                4.4 Current Opportunities in the Market              

5. Market Segmentation                              

                5.1 By Diagnosis               

                                5.1.1 Digital Rectal Examination

                                5.1.2 Faecal Occult Blood Test

                                5.1.3 Flexible Sigmoidoscopy

                                5.1.4 Colonoscopy

                                5.1.5 Virtual Colonoscopy

                5.2 By Treatment            

                                5.2.1 Surgery and Radiation Therapy

                                5.2.2 Chemotherapy

                                5.2.3 Targeted Therapies

                                5.2.4 Resistance to Pharmacological Therapies

6. Geographical Analysis                              

                                6.1 Introduction

                                6.2 U.K

                                6.3 Spain

                                6.4 Germany

                                6.5 Italy 

                                6.6 France

7. Strategic Analysis                       

                7.1 PESTLE analysis         

                                7.1.1 Political

                                7.1.2 Economic

                                7.1.3 Social

                                7.1.4 Technological

                                7.1.5 Legal

                                7.1.6 Environmental

                7.2 Porter’s Five analysis              

                                7.2.1 Bargaining Power of Suppliers

                                7.2.2 Bargaining Power of Consumers

                                7.2.3 Threat of New Entrants

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry

8. Market Leaders' Analysis                        

                8.1 Abbott Diagnostics  

                                8.1.1 Overview

                                8.1.2 Product Analysis

                                8.1.3 Strategic Evaluation and Operations

                                8.1.4 Financial analysis

                                8.1.5 Legal issues

                                8.1.6 Recent Developments

                                8.1.7 SWOT analysis

                                8.1.8 Analyst View

                8.2 Alere             

                8.3 Beckman Coulter     

                8.4 Clinical Genomics     

                8.5 Companion Dx          

                8.6 Hoffmann La Roche

                8.7 Debiopharm Group 

                8.8 Vaccinogen BD          

9. Competitive Landscape                           

                9.1 Market share analysis            

                9.2 Merger and Acquisition Analysis       

                9.3 Agreements, collaborations and Joint Ventures         

                9.4 New Product Launches         

10. Expert Opinions                        

                10.1 Market Outlook     

                10.2 Investment Opportunities 

Appendix                           

                a) List of Tables

                b) List of Figures              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market

 

  1. Europe Colorectal Cancer Market, By Region, From 2021 to 2026 (USD Billion)
  2. Europe Colorectal Cancer Market, By Diagnosis, From 2021 to 2026 (USD Billion)
  3. Europe Digital Rectal Examination Market, By Region, From 2021 to 2026 (USD Billion)
  4. Europe Faecal Occult Blood Test Market, By Region, From 2021 to 2026 (USD Billion)
  5. Europe Flexible Sigmoidoscopy Market, By Region, From 2021 to 2026 (USD Billion)
  6. Europe Colonoscopy Market, By Region, From 2021 to 2026 (USD Billion)
  7. Europe Virtual Colonoscopy Market, By Region, From 2021 to 2026 (USD Billion)
  8. Europe Colorectal Cancer Market, By Treatment, From 2021 to 2026 (USD Billion)
  9. Europe Surgery and Radiation Therapy Market, By Region, From 2021 to 2026 (USD Billion)
  10. Europe Chemotherapy Market, By Region, From 2021 to 2026 (USD Billion)
  11. Europe Targeted Therapies Market, By Region, From 2021 to 2026 (USD Billion)
  12. Europe Resistance to Pharmacological Therapies Market, By Region, From 2021 to 2026 (USD Billion)
  13. U.K Colorectal Cancer Market, By Diagnosis, From 2021 to 2026 (USD Billion)
  14. U.K Colorectal Cancer Market, By Treatment, From 2021 to 2026 (USD Billion)
  15. Spain Colorectal Cancer Market, By Diagnosis, From 2021 to 2026 (USD Billion)
  16. Spain Colorectal Cancer Market, By Treatment, From 2021 to 2026 (USD Billion)
  17. Germany Colorectal Cancer Market, By Diagnosis, From 2021 to 2026 (USD Billion)
  18. Germany Colorectal Cancer Market, By Treatment, From 2021 to 2026 (USD Billion)
  19. Italy Colorectal Cancer Market, By Diagnosis, From 2021 to 2026 (USD Billion)
  20. Italy Colorectal Cancer Market, By Treatment, From 2021 to 2026 (USD Billion)
  21. France Colorectal Cancer Market, By Diagnosis, From 2021 to 2026 (USD Billion)
  22. France Colorectal Cancer Market, By Treatment, From 2021 to 2026 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample